Ms Jean Spinks - Researcher Profile

We do not have a photograph of this person yet.

Address

Centre for Health Economics
Building 75, Clayton

Biography

Jean works in the Faculty of Business & Economics at Monash University as a Research Fellow.

Qualifications

MASTER HEALTH SCIENCE (PUBLIC HEALTH PRACTICE)
Institution: Latrobe University
Year awarded: 2005
MASTER PUBLIC HEALTH
Institution: Monash University
Year awarded: 2002
BACHELOR OF PHARMACY
Institution: Sydney University
Year awarded: 1995

Publications

Journal Articles

Manderson, L.H., Oldenburg, B.F., Lin, V., Hollingsworth, B.P., De Courten, M.F., Canaway, R.E., Spinks, J.M., 2012, Care seeking, complementary therapy and herbal medicine use among people with type 2 diabetes and cardiovascular disease CAMELOT Phase II: surveying for diversity, Australian Journal of Herbal Medicine [P], vol 24, issue 2, National Herbalists Association of Australia, Australia, pp. 46-55.

Spinks, J.M., Hollingsworth, B.P., 2012, Policy implications of complementary and alternative medicine use in Australia: Data from the National Health Survey, Journal of Alternative and Complementary Medicine [P], vol 18, issue 4, Mary Ann Liebert Inc Publishers, New Rochelle USA, pp. 371-378.

Spinks, J., Richardson, J., 2011, Paying the right price for pharmaceuticals: A case study of why the comparator matters, Australian Health Review [P], vol 35, issue 3, CSIRO Publishing, Collingwood Vic Australia, pp. 267-272.

Spinks, J.M., Hollingsworth, B.P., 2009, Are the economics of complementary and alternative medicine different to conventional medicine?, Expert Review of Pharmacoeconomics and Outcomes Research [P], vol 9, issue 1, Expert Reviews Ltd, UK, pp. 1-4.

Spinks, J.M., Hollingsworth, B.P., 2009, Cross-country comparisons of technical efficiency of health production: A demonstration of pitfalls, Applied Economics [P], vol 41, issue 4, Routledge, United Kingdom, pp. 417-427.

Owen, A.J., Spinks, J.M., Meehan, A.D., Robb, T., Hardy, M., Kwasha, D., Wlodarczyk, J.H., Reid, C.M., 2008, A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: the Bosentan Patient Registry, Journal of Medical Economics, vol 11, issue 2, Informa Healthcare, United Kingdom, pp. 235-243.